Sign in

NCT04538157Completed

Comprehensive Geriatric Assessment for Frail Older People With Chronic Kidney Disease - The GOAL Trial

Comprehensive Geriatric Assessment for Frail Older People With Chronic Kidney Disease to Increase Attainment of Patient-Identified Goals - A Cluster Randomised Controlled Trial - The GOAL Trial

Source: ClinicalTrials.gov · Last updated 5 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The GOAL trial addresses patient-prioritised research topics and outcomes and will be conducted, disseminated and implemented in partnership with patients and their caregivers. This will be the first study, internationally, to evaluate the clinical and cost effectiveness of Comprehensive Geriatric Assessment (CGA), a highly promising intervention for improving patient-important health outcomes in frail older people with Chronic Kidney Disease (CKD).

Status (registry)
Completed
Study type
Interventional
Enrollment
240 (actual)
First submitted
6 Aug 2020
Start date
15 Mar 2021
Primary completion date
30 Jun 2024
Lead sponsor
The University of Queensland
NCT number
NCT04538157

What you commit to

  • Study type: Interventional
  • Participants enrolled: 240
  • From 15 Mar 2021 to the primary completion date, 30 Jun 2024
  • 15 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unable to provide informed consent and/or participate in the Goal Attainment Scaling process due to cognitive impairment or another reason.

Other

  • Estimated life expectancy of less than 12 months.

Who the study is looking for

  • Moderate to severe CKD as determined by the treating nephrologist:
  • Stage 3 = eGFR 30 - 59 ml/min/1.73 m2
  • Stage 4 = eGFR 15 - 29 ml/min/1.73 m2
  • Stage 5/5D = eGFR below 15 ml/min/1.73m2, including patients receiving dialysis
  • Aged ≥65 years, or ≥ 55 years if Aboriginal or Torres Strait Islander
    • For inclusion in enrolment:
  • Frailty Index \>0.25 (FI-CKD tool)

Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (15)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Adelaide Hospital
Coordinator of this site? Confirm its status
AdelaideAustraliaUnknown status
Blacktown Hospital
Coordinator of this site? Confirm its status
BlacktownAustraliaUnknown status
Princess Alexandra Hospital
Coordinator of this site? Confirm its status
BrisbaneAustraliaUnknown status
Cairns Hospital
Coordinator of this site? Confirm its status
CairnsAustraliaUnknown status
Concord Repatriation General Hospital
Coordinator of this site? Confirm its status
ConcordAustraliaUnknown status
Renal Research Gosford
Coordinator of this site? Confirm its status
GosfordAustraliaUnknown status
Austin Health
Coordinator of this site? Confirm its status
HeidelbergAustraliaUnknown status
Liverpool Hospital
Coordinator of this site? Confirm its status
LiverpoolAustraliaUnknown status
Logan Hospital
Coordinator of this site? Confirm its status
Logan CityAustraliaUnknown status
Sir Charles Gairdner Hospital
Coordinator of this site? Confirm its status
NedlandsAustraliaUnknown status
Royal Perth Hospital
Coordinator of this site? Confirm its status
PerthAustraliaUnknown status
Gold Coast Hospital
Coordinator of this site? Confirm its status
SouthportAustraliaUnknown status
Western Health
Coordinator of this site? Confirm its status
St AlbansAustraliaUnknown status
Toowoomba Hospital
Coordinator of this site? Confirm its status
ToowoombaAustraliaUnknown status
Townsville Hospital
Coordinator of this site? Confirm its status
TownsvilleAustraliaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.